Financial Year |
March 31 2023 |
Monetary Funds |
109,790,539.42 |
Held-for-trading Financial Assets |
325,686.20 |
Notes Receivable |
62,760,991.49 |
Accounts Receivable |
229,417,315.46 |
Advances to Suppliers |
24,968,263.36 |
Other Receivables |
1,478,560.29 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
293,228,099.56 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
-- |
Total Current Assets |
842,720,957.33 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
255,494,689.09 |
Under-construction Projects |
83,349,932.99 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
44,356,717.37 |
R&D expenses |
-- |
Goodwill |
235,937.86 |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
7,434,210.74 |
Other Non-Current Assets |
2,491,068.18 |
Sub-Total of Non-Current Assets |
414,849,207.93 |
Total Assets |
1,257,570,165.26 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
141,903,802.30 |
Accounts Received In Advance |
383,182.03 |
Employee Compensation Payable |
13,889,370.16 |
Taxes Payable |
8,169,269.22 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
4,719,836.05 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
60,789,627.31 |
Sub-Total of Current Liabilities |
230,421,686.38 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
900,577.38 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
7,522,551.49 |
Total Liabilities |
237,944,237.87 |
Paid-In Capital(Or Share Stock) |
216,906,174.00 |
Capital Surplus |
184,442,411.63 |
Surplus Reserve |
86,145,045.28 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
532,132,296.48 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,019,625,927.39 |
Owner's Equity(Stockholder's Equity) |
1,019,625,927.39 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,257,570,165.26 |